Expression of muscarinic receptor subtypes in rat gastric smooth muscle: Effect of M3 selective antagonist on gastric motility and emptying

Digestive Diseases and Sciences

Volumn 42, Issue 5, 1997, Pages 907-914

  Lin, Sheng ^a   Kajimura, Masayoshi ^a   Takeuchi, Ken ^a   Kodaira, Makoto ^a   Hanai, Hiroyuki ^a   Kaneko, Eizo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

gastric emptying; gastric motility; M3 antagonist; muscarinic acetylcholine receptor subtype; smooth muscle

Indexed keywords

ATROPINE; GLUCAGON; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OTENZEPAD; RECEPTOR SUBTYPE; SCOPOLAMINE BUTYL BROMIDE; UNCLASSIFIED DRUG; ZAMIFENACINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; HEART RATE; INTESTINE ENDOSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH MUSCLE;

ANIMALS; ATROPINE; BUTYLSCOPOLAMMONIUM BROMIDE; DIOXOLES; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; GLUCAGON; MALE; MUSCARINIC ANTAGONISTS; MUSCLE, SMOOTH; PIPERIDINES; PIRENZEPINE; POLYMERASE CHAIN REACTION; RATS; RECEPTORS, MUSCARINIC; STOMACH;

EID: 0031010392     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018808329603     Document Type: Article

References (25)

1. Ross WA: Premedication for upper gastrointestinal endoscopy. Gastrointest Endosc 35(2):120-126, 1989
2. Laufer I: Contrast Fluoroscopy and Radiography of the Alimentary Tract. In Gastroenterology. WS Haubrich, F Schaffner, JE Berk (eds). Philadelphia, WB Saunders, 1995, pp. 186-198
3. Iwano T, Toyonaga A, Harada H, Harada K, Ban S, Ikegami M, Tanikawa K: Arterial oxygen desaturation during non-sedated diagnostic upper gastrointestinal endoscopy. Gastrointest Endosc 40:277-280, 1994
4. Berstein G, Haga T: Molecular Aspects of Muscarinic Receptors. In Current Aspects of Neurosciences, vol 1. NN Osborne (eds). New York, Macmillan Press, 1990, pp. 245-284
5. Houghton LA, Rogers J, Whorwell PJ, Cambell FC, Raimundo A, Goka J: Zamifenacine (UK76-654) reduces meal-stimulated colonic motor activity in patients with irritable bowel syndrome (IBS) Gastroenterology 104(4):A523, 1993
6. Kajimura M, Reuben MA, Sachs G: The muscarinic receptor gene expressed in rabbit parietal cells is the m3 subtype. Gastroenterology 103:870-875, 1992
7. Bonner TI, Young AC, Brann MR, Buckley NJ: Cloning and expression of human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1:403-410, 1988
8. Bonner TI, Buckley NJ, Young AC, Brann MR: Identification of a family of muscarinic acetylcholine receptor genes. Science 237:527-532, 1987
9. 2. A possible explanation of cytoprotection. Dig Dis Sci 30(12):1181-1188, 1985
10. Scarpignato C, Capovilla T, Bertaccini G: Action of caerulein on gastric emptying of the conscious rat. Arch Int Pharmacodyn 246:286-294, 1980
11. Tache Y, Maeda-Hagiwara M, Turkelson CM: Central nervous system action of corticotropin-releasing factor to inhibit gastric emptying in rats. Am J Physiol 253(16):G241-G245, 1987
12. Maeda A, Kubo T, Mishina M, Numa S: Tissue distribution of mRNAs encoding muscarinic acetylcholine receptor subtypes. FEBS Lett 239:339-342, 1988
13. Hammer R, Giachetti A: Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci 31:2991-2998, 1982
14. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ: Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J 6(13):3923-3929, 1987
15. Wall SJ, Yasuda RP, Wolfe BB: Development of an antiserum against m3 muscarinic receptors: Distribution of m3 receptors in rat tissues and clonal cell lines. Mol Pharmacol 40:783-789, 1991
16. Witt-Enderby PA, Yamamura HI, Halonen M, Lai J, Palmer JD, Bloom JW: Regulation of airway muscarinic cholinergic receptor subtypes by chronic anticholinergic treatment. Mol Pharmacol 47(3):485-490, 1995
17. Gu ZF, Jensen RT, Maton PN: A primary role tor protein kinase A in smooth muscle relaxation induced by adrenergic agonists and neuropeptide. Am J Physiol 263:G360-G364, 1992
18. Ohta T, Ito S, Noto T, Tachibana R, Nakazato Y, Ohga A: The inhibitory action of cyclic AMP on responses to carbachol dependent on calcium stores in rat gastric smooth muscle. J Physiol 453:367-384, 1992
19. Thomas EA, Baker SA, Ehlert FJ: Functional role for the muscarinic receptor in smooth muscle of guinea pig ileum. Mol Pharmacol 44:102-110, 1993
20. Wallis RM, Alker D, Burges RA, Cross PE, Miner WD, Newgreen DT, Quinn P: Zamifenacine: A novel muscarinic M3 receptor antagonist. Gastroenterology 104(4):A597, 1993
21. Daneshmend TK, Bell GD, Logan RFA: Sedation for upper gastrointestinal endoscopy: results of a nationwide survey. Gut 32:12-15, 1991
22. Keeffe EB, O'Connor KW: ASGE survey of endoscopic sedation and monitoring practices. Gastrointest Endosc 36:s13-s18, 1990
23. Froehich F, Fried M, Gonvers JJ: Conscious sedation, clinically relevant complications and monitoring of endoscopy: Results of a nationwide survey in Switzerland. Endoscopy 26:231-234, 1994
24. Arrowsmith JB, Gerstman BB, Fleischer DE, Benjamin SB: Results from the American Society for Gastrointestinal Endoscopy/US Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest Endosc 37:421-427, 1991
25. Op den Orth JO: Use of Barium in Evaluation of Disorders of the Upper gastrointestinal Tract: Current Status. Radiology 173:601-608, 1989